Xiaojun Cai

408 citations
18 papers · 329 indexed · h-index 9
Topics
Metabolomics and Mass Spectrometry Studies (5 papers)Analytical Chemistry and Chromatography (4 papers)Natural product bioactivities and synthesis (4 papers)
Partner nations
China

In The Last Decade

Xiaojun Cai

17 papers receiving 315 citations

Peers

Xiaojun Cai
Comparison fields: 5 of 76
  • Molecular Biology 158
  • Complementary and alternative medicine 84
  • Pharmacology 74
  • Pharmacology 55
  • Plant Science 52
Replace Hairong Zeng with:
Hairong Zeng China
Chiu‐Li Kao Taiwan
Baolian Wang China
P.-D.L. Chao Taiwan
Shitang Ma China
Mohd Yaseen Malik India
Chengtao Lu China
Jiamu Ma China
Xiaojun Cai relative to Hairong Zeng China Hairong Zeng's profile →
Citations per field
00.5×3.6×
Hairong Zeng · 1×
Citations per year

Countries citing papers authored by Xiaojun Cai

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Cai more than expected).

Fields of papers citing papers by Xiaojun Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Cai. The network helps show where Xiaojun Cai may publish in the future.

Co-authorship network of co-authors of Xiaojun Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Cai. A scholar is included among the top collaborators of Xiaojun Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Cai. Xiaojun Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 6
2 1
3 0
4 21
5 13
6 4
7 5
8 12
9 16
10 40
11 80
12 16
13 6
14 75
15 8
16 6
17 16
18
Enantioseparation of racemic naproxen esters on four cellulose derivative chiral columns and chiral recognition mechanism
4

About Xiaojun Cai

Xiaojun Cai is a scholar working on Pharmacology, Biochemistry and Complementary and alternative medicine, having authored 18 papers that have together received 329 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (5 papers), Analytical Chemistry and Chromatography (4 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Complementary and alternative medicine (84 citations), Pharmacology (74 citations) and Analytical Chemistry (40 citations). Xiaojun Cai has collaborated with scholars based in China. Frequent co-authors include Zheng Xiang, Su Zeng, Dahui Chen, Yuepiao Cai, Faqing Ye, Dongsheng Cao, Shaohua Shi, Hao Sun, Hao Sun and Chunxiu Pan. Their work appears in journals such as PLoS ONE, Annals of the New York Academy of Sciences and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026